Navigation Links
Cancer study finds adolescents don't get same access to latest treatments as younger patients
Date:1/15/2008

The overall survival rate from cancer now is lower in older adolescents and young adults with cancer than in younger children, in part because of a lack of access to clinical trials nationally for the older age group, according to a study by pediatric oncologists at Childrens Hospital of Pittsburgh of UPMC.

Nationally, cure rates in children younger than 15 with cancer have improved dramatically over the last 30 years, increasing from 60 percent to approximately 85 percent at five years from the time of diagnosis. In contrast, similar improvements in survival rates have not been seen in adolescents and young adults ages 1522, with cure rates remaining steady at approximately 70 percent throughout the same time period.

This can be attributed to the fact that adolescents and young adults dont have the same access to cutting-edge cancer treatments provided though clinical trials, according to the study led by Peter Shaw, MD, a pediatric hematologist/oncologist at Childrens Hospital and the director of the hospitals Adolescent and Young Adult (AYA) Oncology Program.

The study is published in the December issue of the Journal of Pediatric Hematology/Oncology.

Research has shown that patients who are enrolled in clinical trials offering the most advanced cancer treatments do better than patients who receive conventional treatment, Dr. Shaw said. Adolescents and young adults with cancer are less likely than younger children to be enrolled in clinical trials for two important reasons: the first factor is that AYA patients are frequently treated by adult oncologists at hospitals that arent participating in clinical trials designed for cancers occurring in the pediatric and adolescent age groups. Our study demonstrated the second reason, which is that nationally, there are many more clinical trials available for the types of malignancies that most often occur in the younger patients

Drs. Shaw and study co-author A. Kim Ritchey, MD, chief of the Division of Pediatric Hematology/Oncology at Childrens and vice chair of Clinical Affairs in the Department of Pediatrics, studied 640 new oncology patients treated at Childrens between July 1, 2001, and June 30, 2006. The patients ranged in age from birth to 22 years old. The study found that:

  • 38 percent of patients younger than 15 were enrolled in a clinical trial.

  • 27 percent of AYA patients were enrolled in a clinical trial.

  • 41 percent of patients younger than 15 were not treated on a clinical trial because one was not available.

  • 57 percent of AYA patients were not treated on a clinical trial because one was not available.

These findings underscore the need for AYA patients to be treated at centers such as childrens hospitals that are involved in national cooperatives offering clinical trials of new treatments for pediatric and adolescent cancers, Dr. Ritchey said. There also is a need for more national trials to be opened for AYA patients and the types of malignancies most common to them.

The national Childrens Oncology Group of which Childrens is a member has an AYA subcommittee on which Dr. Shaw serves that currently is evaluating the types of cancers affecting AYA patients and ways to increase clinical trials available to these patients, according to Drs. Shaw and Ritchey.

One strategy for ensuring that AYA patients are treated by oncologists who are most up-to-date on clinical trials and cutting-edge treatment programs is for pediatric oncology divisions to establish AYA oncology programs in cooperation with adult oncology counterparts.

In 2006, Childrens partnered with colleagues from the University of Pittsburgh Cancer Institute to establish an unparalleled AYA Oncology Program. It combines the latest and most effective treatment options with a comprehensive family-centered approach to care that addresses the physical, psychological and emotional needs of adolescents and young adults diagnosed with cancer.


'/>"/>

Contact: Marc Lukasiak
marc.lukasiak@chp.edu
412-692-7919
Children's Hospital of Pittsburgh
Source:Eurekalert

Related medicine news :

1. National Cervical Cancer Coalition (NCCC) State Chapters to Provide Parents With Educational Forum to Discuss Cervical Cancer and HPV Vaccines
2. Combined HRT increases risk of lobular breast cancer fourfold after just 3 years of use
3. Proteomic profiling shown more accurate than traditional biomarkers in identifying liver cancer
4. Hormonal dietary supplements might promote prostate cancer progression
5. Local Oncology Group Leads Online Effort to Revolutionize Cancer Care
6. California Affiliates of Susan G. Komen for the Cure Convene Celebrities, Breast Cancer Survivors and Activists to Challenge Elected Officials to Strengthen Breast Cancer Services
7. Fruit flies all aglow light the way to cancer prevention
8. Susan G. Komen for the Cures Circle of Promise and The Links, Incorporated Unite to Rewrite the Story on African Americans and Breast Cancer
9. Vaccines for Ovarian and Breast Cancer in Early Trials
10. Stem cells make bone marrow cancer resistant to treatment
11. Independence Blue Cross Delivers Important Reminder to Women during Cervical Cancer Awareness Month
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... ... is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is ...
(Date:6/24/2016)... ... 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ... raise to $12 an hour by 2020 and then adjusting it yearly to increase at ... the minimum wage, assure the wage floor does not erode again, and make future increases ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... today at the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra ... authored journal articles published in Emergency Medicine Practice and Pediatric Emergency ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions today ... cultivation and processing operations at its production facility, and opened its first two ... the manufacturer of a complete system of proactive air and surface purification solutions ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... Bracket , a leading clinical trial technology ... outcomes platform, Bracket eCOA (SM) 6.0, at the 52 ... 30, 2016 in Philadelphia , Pennsylvania.  A ... product of its kind to fully integrate with RTSM, will ... 6.0 is a flexible platform for electronic clinical outcomes assessments ...
(Date:6/23/2016)... June 23, 2016 Revolutionary technology ... Oticon , industry leaders in advanced audiology and ... Oticon Opn ™, the world,s first internet connected ... for IoT devices.      (Photo: http://photos.prnewswire.com/prnh/20160622/382240 ... a number of ,world firsts,: , TwinLink™ ...
Breaking Medicine Technology: